{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:57:04Z","timestamp":1759334224273,"version":"build-2065373602"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,30]]},"DOI":"10.7759\/cureus.93555","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:53:16Z","timestamp":1759236796000},"source":"Crossref","is-referenced-by-count":0,"title":["Limited Predictive Performance of the SAMe-TT\u2082R\u2082 Score for Suboptimal Time in Therapeutic Range (TTR) in Thai Patients With Atrial Fibrillation: A Retrospective Analysis"],"prefix":"10.7759","author":[{"given":"Panisa","family":"Manasirisuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thunchanok","family":"Kuichanuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witsarut","family":"Manasirisuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08753.x","article-title":"Guidelines on oral anticoagulation with warfarin - fourth edition","volume":"154","author":"Keeling D","year":"2011","unstructured":"Keeling D, Baglin T, Tait C, et al.. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol. 2011, 154:311-24. 10.1111\/j.1365-2141.2011.08753.x","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2364825","article-title":"Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study","volume":"56","author":"Lehto M","year":"2024","unstructured":"Lehto M, Luojus A, Halminen O, et al.. Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study. Ann Med. 2024, 56:2364825. 10.1080\/07853890.2024.2364825","journal-title":"Ann Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-015-0120-9","article-title":"International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation","volume":"15","author":"Nelson WW","year":"2015","unstructured":"Nelson WW, Desai S, Damaraju CV, Lu L, Fields LE, Wildgoose P, Schein JR. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation. Am J Cardiovasc Drugs. 2015, 15:205-11. 10.1007\/s40256-015-0120-9","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188482","article-title":"The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: a systematic review and meta-regression analysis","volume":"12","author":"Vestergaard AS","year":"2017","unstructured":"Vestergaard AS, Skj\u00f8th F, Larsen TB, Ehlers LH. The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: a systematic review and meta-regression analysis. PLoS One. 2017, 12:e0188482. 10.1371\/journal.pone.0188482","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder IC","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al.. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024, 45:3314-414. 10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.35755\/jmedassocthai.2023.12.13925","article-title":"Optimal INR level in nonvalvular atrial fibrillation patients in Thailand: a multi-site study","volume":"106","author":"Thongsri T","year":"2023","unstructured":"Thongsri T, Chanprasertpinyo W, Wongtheptien W, Wattanasombat S. Optimal INR level in nonvalvular atrial fibrillation patients in Thailand: a multi-site study. J Med Assoc Thai. 2023, 106:1147-53. 10.35755\/jmedassocthai.2023.12.13925","journal-title":"J Med Assoc Thai"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.08.236","article-title":"Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry","volume":"223","author":"Oh S","year":"2016","unstructured":"Oh S, Goto S, Accetta G, et al.. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry. Int J Cardiol. 2016, 223:543-7. 10.1016\/j.ijcard.2016.08.236","journal-title":"Int J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194208","article-title":"Clinical usefulness of the SAMe-TT2R2 score: a systematic review and simulation meta-analysis","volume":"13","author":"van Miert JH","year":"2018","unstructured":"van Miert JH, Bos S, Veeger NJ, Meijer K. Clinical usefulness of the SAMe-TT2R2 score: a systematic review and simulation meta-analysis. PLoS One. 2018, 13:e0194208. 10.1371\/journal.pone.0194208","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT\u2082R\u2082 score","volume":"144","author":"Apostolakis S","year":"2013","unstructured":"Apostolakis S, Sullivan RM, Olshansky B, Lip GY. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT\u2082R\u2082 score. Chest. 2013, 144:1555-63. 10.1378\/chest.13-0054","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61994-2","article-title":"Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial","volume":"385","author":"Mega JL","year":"2015","unstructured":"Mega JL, Walker JR, Ruff CT, et al.. Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015, 385:2280-7. 10.1016\/S0140-6736(14)61994-2","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2023.381","article-title":"Modified application of SAMe-TT2R2 scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants","volume":"39","author":"Jeon SW","year":"2024","unstructured":"Jeon SW, Lee N, Lee KH, et al.. Modified application of SAMe-TT2R2 scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants. Korean J Intern Med. 2024, 39:458-68. 10.3904\/kjim.2023.381","journal-title":"Korean J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/00185787241300293","article-title":"Assessing the predictive value of the SAMe-TT2R2 score for poor anticoagulation control in a diverse ethnic population","author":"Mohamed S","year":"2024","unstructured":"Mohamed S, Nik Abdul Rahman NN, Tan JY, Selvam T, Zulkifly HH. Assessing the predictive value of the SAMe-TT2R2 score for poor anticoagulation control in a diverse ethnic population. Hosp Pharm. 2024, 00185787241300293. 10.1177\/00185787241300293","journal-title":"Hosp Pharm"},{"key":"ref13","article-title":"SAMe-TT\u2082R\u2082 score for prediction of anticoagulation control in Thai patients with non-valvular atrial fibrillation","volume":"104","author":"Leedumrongwattanakul A","year":"2021","unstructured":"Leedumrongwattanakul A. SAMe-TT\u2082R\u2082 score for prediction of anticoagulation control in Thai patients with non-valvular atrial fibrillation. J Med Assoc Thai. 2021, 104:959-63.","journal-title":"J Med Assoc Thai"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2019143","article-title":"SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation","volume":"61","author":"Krittayaphong R","year":"2020","unstructured":"Krittayaphong R, Winijkul A, Pirapatdit A, et al.. SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation. Singapore Med J. 2020, 61:641-6. 10.11622\/smedj.2019143","journal-title":"Singapore Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-023-00623-3","article-title":"SAMe-TT(2)R(2) score to predict time in therapeutic range of vitamin K antagonists in Asian and non-Asian patients: a systematic review and meta-analysis","volume":"24","author":"Poonchuay N","year":"2024","unstructured":"Poonchuay N, Saokaew S, Incomenoy S. SAMe-TT(2)R(2) score to predict time in therapeutic range of vitamin K antagonists in Asian and non-Asian patients: a systematic review and meta-analysis. Am J Cardiovasc Drugs. 2024, 24:211-40. 10.1007\/s40256-023-00623-3","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231166643","article-title":"SAMe-TT(2)R(2) to predict clinical outcomes and time in therapeutic range in patients on vitamin K antagonists: a systematic review and meta-analysis","volume":"58","author":"Incomenoy S","year":"2024","unstructured":"Incomenoy S, Saokaew S, Poonchuay N. SAMe-TT(2)R(2) to predict clinical outcomes and time in therapeutic range in patients on vitamin K antagonists: a systematic review and meta-analysis. Ann Pharmacother. 2024, 58:126-39. 10.1177\/10600280231166643","journal-title":"Ann Pharmacother"},{"key":"ref17","article-title":"Proportion of Thai patients with atrial \u03d0ibrillation receiving warfarin with labile INR in each group of SAMeTT2R2 score","volume":"101","author":"Methavigul K","year":"2018","unstructured":"Methavigul K. Proportion of Thai patients with atrial \u03d0ibrillation receiving warfarin with labile INR in each group of SAMeTT2R2 score. J Med Assoc Thai. 2018, 101:189-93.","journal-title":"J Med Assoc Thai"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2024.08.011","article-title":"Impact of educational intervention on anticoagulation control using SAMe-TT(2)2R(2) score-guided strategy in atrial fibrillation","volume":"5","author":"Phrommintikul A","year":"2025","unstructured":"Phrommintikul A, Nathisuwan S, Wongcharoen W, et al.. Impact of educational intervention on anticoagulation control using SAMe-TT(2)2R(2) score-guided strategy in atrial fibrillation. JACC Asia. 2025, 5:205-13. 10.1016\/j.jacasi.2024.08.011","journal-title":"JACC Asia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S472597","article-title":"Warfarin adherence and its associated factors in Thai older adults with atrial fibrillation","volume":"17","author":"Poungkaew A","year":"2024","unstructured":"Poungkaew A, Tankumpuan T, Riangkam C, et al.. Warfarin adherence and its associated factors in Thai older adults with atrial fibrillation. J Multidiscip Healthc. 2024, 17:4455-64. 10.2147\/JMDH.S472597","journal-title":"J Multidiscip Healthc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006814","article-title":"Prediction score for anticoagulation control quality among older adults","volume":"6","author":"Lin KJ","year":"2017","unstructured":"Lin KJ, Singer DE, Glynn RJ, et al.. Prediction score for anticoagulation control quality among older adults. J Am Heart Assoc. 2017, 6:10.1161\/JAHA.117.006814","journal-title":"J Am Heart Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)","volume":"163","author":"Kakkar AK","year":"2012","unstructured":"Kakkar AK, Mueller I, Bassand JP, et al.. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2012, 163:13-9.e1. 10.1016\/j.ahj.2011.09.011","journal-title":"Am Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.04.092","article-title":"Integrating genotypes in the SAMe-TT(2)R(2) score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin","volume":"241","author":"Liu J","year":"2017","unstructured":"Liu J, Wang N, Qin L, et al.. Integrating genotypes in the SAMe-TT(2)R(2) score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin. Int J Cardiol. 2017, 241:358-63. 10.1016\/j.ijcard.2017.04.092","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408764-limited-predictive-performance-of-the-same-ttr-score-for-suboptimal-time-in-therapeutic-range-ttr-in-thai-patients-with-atrial-fibrillation-a-retrospective-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:53:17Z","timestamp":1759236797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408764-limited-predictive-performance-of-the-same-ttr-score-for-suboptimal-time-in-therapeutic-range-ttr-in-thai-patients-with-atrial-fibrillation-a-retrospective-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.93555","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}